CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-12 | Donovan Joanne M. CMO | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-08-12 | MOORE JOHN R General Counsel | Option exercise | +5,781 | 15,995 | ||
| 2026-08-12 | MOORE JOHN R General Counsel | Option exercise | +6,718 | 22,713 | ||
| 2026-08-12 | MOORE JOHN R General Counsel | Sale | −2,439 | $43.81 | $107K | 20,274 |
| 2026-08-12 | MOORE JOHN R General Counsel | Sale | −59 | $44.41 | $3K | 20,215 |
| 2026-08-12 | MOORE JOHN R General Counsel | Sale | −99 | $44.50 | $4K | 20,116 |
| 2026-08-12 | MOORE JOHN R General Counsel | Sale | −2,419 | $43.80 | $106K | 17,697 |
| 2026-08-12 | MOORE JOHN R General Counsel | Option exercise · Restricted Stock Units | −5,781 | 11,563 | ||
| 2026-08-12 | MOORE JOHN R General Counsel | Option exercise · Restricted Stock Units | −6,718 | 20,157 | ||
| 2026-08-12 | MOORE JOHN R General Counsel | Grant or award · Restricted Stock Units | +32,500 | 32,500 | ||
| 2026-08-12 | MOORE JOHN R General Counsel | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-08-12 | KOCH KEVIN President and CEO | Option exercise | +17,969 | 48,584 | ||
| 2026-08-12 | KOCH KEVIN President and CEO | Option exercise | +21,875 | 70,459 | ||
| 2026-08-12 | KOCH KEVIN President and CEO | Sale | −8,782 | $43.64 | $383K | 61,677 |
| 2026-08-12 | KOCH KEVIN President and CEO | Sale | −8,276 | $43.66 | $361K | 53,401 |
| 2026-08-12 | KOCH KEVIN President and CEO | Sale | −913 | $44.33 | $40K | 52,488 |
| 2026-08-12 | KOCH KEVIN President and CEO | Option exercise · Restricted Stock Units | −17,969 | 35,938 | ||
| 2026-08-12 | KOCH KEVIN President and CEO | Option exercise · Restricted Stock Units | −21,875 | 65,625 | ||
| 2026-08-12 | KOCH KEVIN President and CEO | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2026-08-12 | KOCH KEVIN President and CEO | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 |
Page 3 of 26 · 509 trades